Categories
AFNewsNG Logo
News Special Report

Stop Using malaria drugs to treat Covid-19 - Doctors warns

Thompson Nsisongabasi

Mar 29, 2020

The prospect that a pair of malaria drugs will become go-to medications for treating COVID-19 before they've been rigorously tested is prompting new safety warnings from heart specialists and other doctors and experts.

READ ALSO: Ohanaeze Accuses FG Of Hatred For Ndigbo | READ MORE

President Donald Trump has touted the drugs chloroquine and hydroxychloroquine as a potential "game changerÔÇØ for patients sickened by the novel coronavirus, and federal officials have asked pharmaceutical manufacturers to make their stocks of these drugs available for immediate use.

READ ALSO: Why FG Suspended N-Power Programme | READ DETAILS

But as the medications begin pouring into hospital pharmacies and physicians begin prescribing them, their potential side effects are raising alerts.

READ ALSO: SENATE PRESIDENT: NGIGE DESCRIBES ORJI KALU, UWAJIMOGU AS FIT FOR THE SEAT

An article published this week in the Mayo Clinic Proceedings warns that both drugs could prompt dangerous and potentially deadly heart arrhythmias in the 3 million people worldwide who have a congenital cardiac condition - called long QT syndrome - that can cause the heart to beat erratically and lead to sudden death.

READ ALSO: Mother's Day: Abia Government Liaison Officer Honours Women, Says Mothers Shape Future Leaders

In addition, millions of people in the U.S. take medications that prolong the heart's "QT interval,ÔÇØ the span of time it takes the heart's electrical system to recharge between beats.

READ ALSO: INEC SUSPENDS ANNOUNCEMENT OF RESULTS IN IMO STATE

Those people - including patients who take common antidepressants and antipsychotic drugs or any one of a wide range of antibiotics - are probably also at risk of developing a dangerously irregular heartbeat if they take one of the malaria drugs without being closely monitored by a doctor, the article's authors said.

READ ALSO: Why ICPC Is Prosecuting Mike Ozekhome Over a London Property Deal That Has Shaken Nigeria's Legal Circle | READ DETAILS

Roughly 13 per cent of Americans over the age of 12 take an antidepressant medication.

READ ALSO: 2face Idibia Makes Public Apology For Being An Embarrassment |Read details

It's not clear how many more Americans are "QT reactorsÔÇØ - people whose hearts respond to certain drugs with electrical changes that could trigger arrhythmias and sudden cardiac death.

READ ALSO: How a Catholic Priest Slumped and Died While Delivering Homily in Delta Church

With potentially millions of patients taking chloroquine or hydroxychloroquine, the unexpected appearance of these side effects in even a small percentage of them could spell disaster, said Dr. Michael J. Ackerman, a geneticist at the Mayo Clinic in Rochester, Minnesota, who co-authored the new report.

READ ALSO: JUST IN! Commendienne Ada Jesus buried amidst tears in Imo | SEE PHOTOS

"We will pay the piper for this tragic side effect, and we need to make sure we do everything possible to prevent treatment-related sudden death,ÔÇØ said Ackerman, who treats and studies those with congenital heart conditions.

READ ALSO: Bloodbath At Wedding: Bandits Kill 13, Abduct Many In Midnight Attack In Kaduna Community

"We have the tools and we have the knowledgeÔÇØ to avoid sudden cardiac deaths among people treated with the malaria drugs, Ackerman said.

READ ALSO: "Ikwuano Locked Down For Alex OttiÔÇØ - Monday Ubani SAN Sends Strong Message To Opposition

But the medical community will need to be made more aware of this side effect.

READ ALSO: Ofuji Ndị Igbo Sets 2026 Agenda, Promises Greater Community Engagement

He added that if these drugs are to be used safely, doctors will need to screen their patients carefully and devise a plan to monitor their heart rhythms after they're sent home with the drug.

READ ALSO: Ohanaeze Accuses FG Of Hatred For Ndigbo | READ MORE

Meanwhile, a dispatch posted this week to MedPage Today, a blog and medical news service widely read by doctors, warned that chloroquine can cause hemolytic anemia if administered to people with a common genetic condition called G6PD deficiency.

READ ALSO: Why FG Suspended N-Power Programme | READ DETAILS

Hemolytic anemia can lead to shortness of breath, rapid heartbeat, and in severe cases, kidney failure and death.

READ ALSO: SENATE PRESIDENT: NGIGE DESCRIBES ORJI KALU, UWAJIMOGU AS FIT FOR THE SEAT

"Chloroquine is not a harmless panacea for COVID-19,ÔÇØ wrote Dr. Dan J. Vick, a pathologist who teaches healthcare administration at Central Michigan University.

READ ALSO: Mother's Day: Abia Government Liaison Officer Honours Women, Says Mothers Shape Future Leaders

Its use is specifically discouraged in patients with G6PD deficiency.

READ ALSO: INEC SUSPENDS ANNOUNCEMENT OF RESULTS IN IMO STATE

The problem: Many of those patients never know they have G6PD until a new drug or dietary quirk triggers a crisis that prompts red blood cells to break down faster than they can be made.

READ ALSO: Why ICPC Is Prosecuting Mike Ozekhome Over a London Property Deal That Has Shaken Nigeria's Legal Circle | READ DETAILS

The disorder affects between 10 per cent and 14 per cent of African American men in the U.S., and is common in people from the Mediterranean region, Africa and Asia.

READ ALSO: 2face Idibia Makes Public Apology For Being An Embarrassment |Read details

Nearly all patients with G6PD are.

READ ALSO: How a Catholic Priest Slumped and Died While Delivering Homily in Delta Church

Across the world, some 17 clinical trials are testing the safety and effectiveness of chloroquine or hydroxychloroquine against COVID-19.

READ ALSO: JUST IN! Commendienne Ada Jesus buried amidst tears in Imo | SEE PHOTOS

Two clinical trials in the U.S. aim to test whether hydroxycloroquine might prevent illness in U.S. healthcare workers or caregivers who have been exposed COVID-19 patients.

READ ALSO: Bloodbath At Wedding: Bandits Kill 13, Abduct Many In Midnight Attack In Kaduna Community

When medications are tested for use by healthy people who may become ill, regulators typically demand a high level of safety.

READ ALSO: "Ikwuano Locked Down For Alex OttiÔÇØ - Monday Ubani SAN Sends Strong Message To Opposition

A recent review of research on chloroquine as a treatment for COVID-19 concluded that "it seems to be effective in limiting the replicationÔÇØ of the novel coronavirus in laboratory dishes.

READ ALSO: Ofuji Ndị Igbo Sets 2026 Agenda, Promises Greater Community Engagement

Clinical trials in humans and other primates, however, have tempered hopes.

READ ALSO: Ohanaeze Accuses FG Of Hatred For Ndigbo | READ MORE

Both chloroquine and hydroxychloroquine failed to help patients infected with the dengue and chikungunya viruses, and it also failed to protect against the flu.

READ ALSO: Why FG Suspended N-Power Programme | READ DETAILS

The Italian doctors who authored the review in the Journal of Critical Care added that "safety data and data from high-quality clinical trials are urgently needed.ÔÇØ

READ ALSO: SENATE PRESIDENT: NGIGE DESCRIBES ORJI KALU, UWAJIMOGU AS FIT FOR THE SEAT

Meanwhile, the drugs, used to treat lupus and rheumatoid arthritis are also pouring into hospitals and pharmacies in the U.S. and around the world.

READ ALSO: Mother's Day: Abia Government Liaison Officer Honours Women, Says Mothers Shape Future Leaders

Trump has insisted there is "very strong evidenceÔÇØ to support his confidence in the malaria drugs as treatment for COVID-19.

READ ALSO: INEC SUSPENDS ANNOUNCEMENT OF RESULTS IN IMO STATE

"I feel good about it,ÔÇØ he said last week. "That's all it is, just a feeling.ÔÇØ

READ ALSO: Why ICPC Is Prosecuting Mike Ozekhome Over a London Property Deal That Has Shaken Nigeria's Legal Circle | READ DETAILS

The pharmaceutical giant Novartis has pledged a donation of 130 million tablets of hydroxychloroquine, and the generic manufacturer Teva announced it will donate 16 million tablets to hospitals across the United States.

READ ALSO: 2face Idibia Makes Public Apology For Being An Embarrassment |Read details

The generic giant Mylan said it is restarting production of hydroxychloroquine at a manufacturing facility in West Virginia and could readily produce 50 million tablets. (tca/dpa/NAN)

Related Stories

""

— Thompson Nsisongabasi

Join the Conversation

Signed in as Member